| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Odyssey Therapeutics, Inc. (ODTX) has 2 insiders with recent SEC Form 4 filings, including 4 buys and 3 sells. ODTX is classified in the Biotechnology industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.22M | $39.47M | +1.11M | |
| 10% | 1.83M | $32.53M | +553.8K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | Sr One Capital Management, LLC52 | 10% Owner | Sell | 1,780 | $18.00 | $32,040.00 | - | |
| May 11, 2026 | Sr One Capital Management, LLC52 | 10% Owner | Buy | 555,555 | $18.00 | $9,999,990.00 | +19.4% | |
| May 8, 2026 | Dimension Capital Ii, L.P. | Director | Buy | 1,111,111 | $18.00 | $19,999,998.00 | +50.0% |